Metal complexes synthesis and properties

Platinum-based drugs like cisplatin have been cornerstones of cancer chemotherapy for decades, yet their clinical utility is undermined by acquired resistance and significant side effects that researchers are still working to fully explain at the molecular level. The core challenge is understanding exactly how these metal complexes interact with DNA and cellular machinery to kill tumor cells—and why some cancers learn to evade that killing. Beyond platinum, chemists and biologists are now investigating ruthenium and other transition metal compounds that may offer distinct binding modes, alternative targets, or more favorable toxicity profiles. Key open questions include how to predict and overcome resistance mechanisms before they emerge clinically, and whether new metal complexes can be rationally designed to exploit specific vulnerabilities in cancer cells rather than acting broadly.

Works

145,790

Total citations

2,296,769

Keywords

Platinum-Based DrugsCisplatin ResistanceMetal ComplexesAnticancer AgentsMolecular MechanismsDNA Interactions